Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2011 1
2013 2
2015 1
2016 1
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean kohno yuji (36 results)?
Development of a Highly Sensitive Technique for Capturing Renal Cell Cancer Circulating Tumor Cells.
Naoe M, Kusaka C, Ohta M, Hasebe Y, Unoki T, Shimoyama H, Nakasato T, Oshinomi K, Morita J, Fuji K, Ogawa Y, Tsukada M, Sunagawa M, Ishii H. Naoe M, et al. Among authors: fuji k. Diagnostics (Basel). 2019 Aug 14;9(3):96. doi: 10.3390/diagnostics9030096. Diagnostics (Basel). 2019. PMID: 31416266 Free PMC article.
Systematic review and two new cases of primary upper urinary tract neuroendocrine carcinomas.
Nakasato T, Hiramatsu A, Matsui Y, Unoki T, Shimoyama H, Oshinomi K, Morita J, Maeda Y, Naoe M, Fuji K, Ogura H, Homma M, Yamochi T, Takimoto M, Ogawa Y. Nakasato T, et al. Among authors: fuji k. Cancer Treat Res Commun. 2018;17:23-30. doi: 10.1016/j.ctarc.2018.10.003. Epub 2018 Oct 9. Cancer Treat Res Commun. 2018. PMID: 30326420 Free article.
[INITIAL EXPERIENCE OF THE ENZALUTAMIDE TREATMENT FOR CASTRATION-RESISTANT PROSTATE CANCER].
Igarashi A, Fukagai T, Morita M, Hayashi K, Koshikiya A, Ogawa Y, Fuji K, Naoe M, Morita J, Oshinomi K, Nakazato T, Ogawa Y, Matsui Y, Shimada M, Inoue K, Saito K, Ogawa Y, Matsumoto Y, Sasaki H, Ota M, Yamamoto K, Shimoyama H, Imamura Y, Yamagishi M, Tanifuji S, Ishihara M, Shichijyo T, Sato N, Omori K, Matsubara E. Igarashi A, et al. Among authors: fuji k. Nihon Hinyokika Gakkai Zasshi. 2016;107(3):155-161. doi: 10.5980/jpnjurol.107.155. Nihon Hinyokika Gakkai Zasshi. 2016. PMID: 28740046 Free article. Japanese.
Complete response to low-dose sorafenib in a patient with metastatic renal cell carcinoma: A case report.
Morita J, Naoe M, Ogawa Y, Nakasato T, Sugahara M, Morita M, Fuji K, Fukagai T, Sasaki H, Ogawa Y. Morita J, et al. Among authors: fuji k. Can Urol Assoc J. 2013 May-Jun;7(5-6):E351-4. doi: 10.5489/cuaj.1210. Can Urol Assoc J. 2013. PMID: 23766838 Free PMC article.
A pilot study of quality of life of patients with hormone-refractory prostate cancer after gene therapy.
Terao S, Shirakawa T, Acharya B, Miyata M, Hinata N, Tanaka K, Takenaka A, Hara I, Naoe M, Fuji K, Okegawa T, Higashihara E, Kamidono S, Fujisawa M, Gotoh A. Terao S, et al. Among authors: fuji k. Anticancer Res. 2009 May;29(5):1533-7. Anticancer Res. 2009. PMID: 19443362 Free article.
The effects of chlormadinone acetate on lower urinary tract symptoms and erectile functions of patients with benign prostatic hyperplasia: a prospective multicenter clinical study.
Fujimoto K, Hirao Y, Ohashi Y, Shibata Y, Fuji K, Tsuji H, Miyazawa K, Ohtani M, Furuya R, Boku E. Fujimoto K, et al. Among authors: fuji k. Adv Urol. 2013;2013:584678. doi: 10.1155/2013/584678. Epub 2013 May 16. Adv Urol. 2013. PMID: 23762042 Free PMC article.
Influence of hospital and surgeon volumes on operative time, blood loss and perioperative complications in radical nephrectomy.
Yasunaga H, Yanaihara H, Fuji K, Matsuyama Y, Deguchi N, Ohe K. Yasunaga H, et al. Among authors: fuji k. Int J Urol. 2008 Aug;15(8):688-93. doi: 10.1111/j.1442-2042.2008.02098.x. Epub 2008 Jul 10. Int J Urol. 2008. PMID: 18637158 Free article.
[A CASE OF PROSTATE CANCER WITH UNUSUAL PATTERN OF RECURRENCE AFTER RADIOTHERAPY].
Oshinomi K, Fukagai T, Ogawa Y, Sato N, Morita J, Aso T, Igarashi A, Morita M, Naoe M, Fuji K, Ogawa Y. Oshinomi K, et al. Among authors: fuji k. Nihon Hinyokika Gakkai Zasshi. 2015 Jan;106(1):40-4. doi: 10.5980/jpnjurol.106.40. Nihon Hinyokika Gakkai Zasshi. 2015. PMID: 26399130 Japanese.
[Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study].
Fujimoto K, Hirao Y, Ohashi Y, Shibata Y, Fuji K, Tsuji H, Shimizu N, Miyazawa K, Nagata M, Ohtani N, Furuya R, Boku E. Fujimoto K, et al. Among authors: fuji k. Hinyokika Kiyo. 2011 Apr;57(4):177-83. Hinyokika Kiyo. 2011. PMID: 21646847 Free article. Japanese.
Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.
Shirakawa T, Terao S, Hinata N, Tanaka K, Takenaka A, Hara I, Sugimura K, Matsuo M, Hamada K, Fuji K, Okegawa T, Higashihara E, Gardner TA, Kao C, Chung LW, Kamidono S, Fujisawa M, Gotoh A. Shirakawa T, et al. Among authors: fuji k. Hum Gene Ther. 2007 Dec;18(12):1225-32. doi: 10.1089/hum.2007.074. Hum Gene Ther. 2007. PMID: 18021019 Clinical Trial.
Feedback